Aclaris Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $67k | 35k | 1.90 |
| 2025-06-30 | $80k | 56k | 1.42 |
| 2023-09-30 | $241k | 35k | 6.85 |
| 2023-06-30 | $365k | 35k | 10.37 |
| 2023-03-31 | $274k | 34k | 8.09 |
| 2022-12-31 | $534k | 34k | 15.75 |
| 2022-09-30 | $492k | 31k | 15.74 |
| 2022-06-30 | $437k | 31k | 13.96 |
| 2022-03-31 | $453k | 26k | 17.24 |
| 2021-12-31 | $241k | 17k | 14.54 |
| 2021-09-30 | $299k | 17k | 18.00 |
| 2021-06-30 | $291k | 17k | 17.56 |
| 2018-12-31 | $97k | 13k | 7.37 |
| 2018-09-30 | $191k | 13k | 14.52 |
| 2018-06-30 | $263k | 13k | 19.99 |
| 2018-03-31 | $174k | 9.9k | 17.55 |
| 2017-12-31 | $244k | 9.9k | 24.61 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors